Dialysis Market Report and Forecast 2025-2034
Description
The global dialysis market size attained a value of nearly USD 109.51 Billion in 2024. The market is likely to grow at a CAGR of 5.60% during the forecast period of 2025-2034 to attain a value of USD 188.84 Billion by 2034.
Global Dialysis Market Overview
Dialysis is a procedure for people with advanced chronic kidney disease (CKD) or kidney failure. Haemodialysis and peritoneal dialysis are the two types of dialysis that can help in filtering out unwanted fluids and substances from the blood when the kidney of the patient is not working properly. Haemodialysis is the most common form of dialysis in which the blood of the patient is passed through an external dialysis machine and is usually carried out 3 days a week, with each session lasting around 4 hours.
Chronic kidney disease (CKD) results in a progressive loss of kidney function over time. It prompts the patient to undergo dialysis at an advanced stage of the disease if kidney transplantation is not a feasible option. With rise in conditions like diabetes and high blood pressure, the prevalence of CKD is on the rise, posing a greater risk for kidney failure. Approximately 37 million or 1 in 7 Americans have chronic kidney disease, prompting the need for improved and efficient dialysis products and services. Thus, the rising incidence of chronic kidney disease acts as a key driver for dialysis market growth. In addition, technological advancements and the introduction of novel products are also contributing to the increasing market demand.
Surge in Mergers and Acquisition Activities
Increased mergers and acquisitions between healthcare providers have facilitated the diversification of products and services offered in the patient dialysis market. In June 2023, Merit Medical Systems Inc., a leading manufacturer and marketer of medical devices, added USD 132.5 million worth of dialysis and related products in their existing product portfolio. With this acquisition, Merit Medical Systems aimed to expand the portfolio of its specialty dialysis devices to accommodate the rising dialysis market demand. The company purchased medical assets from two medical technology firms based in the United States, Angiodynamics Inc. and Bluegrass Vascular Technologies, for USD 100 million and USD 32.5 million, respectively. Furthermore, it is anticipated that the acquisition initiative will boost the revenue of the firm and solidify its presence in the dialysis devices market.
Increased Fundings to Boost Dialysis Market Share
Significant funding from firms, private investors, government, or non-profit organizations is bolstering the market growth of dialysis devices. In September 2023 , AWAK Technologies headquartered in Singapore, announced that it had raised over USD 20 million in Series B funding. With the help of this funding, the company will complete the ongoing human pre-pivotal clinical trial for its ultraportable peritoneal dialysis (PD) system AWAK PD. In addition, AWAK Technologies plans to develop new products promoting home dialysis and integrated digital solutions to improve the quality of life for chronic kidney disease patients.
Global Dialysis Market Segmentation
The EMR’s report titled “Dialysis Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Treatment Type
North America has a large share of the dialysis market which can attributed to factors such as the increasing number of end stage renal disease (ESRD) patients and the rising prevalence of diabetes and hypertension. Another key factor is the rising technological advancements by the prominent healthcare companies in the region, fuelling the market size significantly. In November 2023 , Baxter International Inc., announced the launch of Sharesource, their digital health platform for home dialysis. It can reduce peritoneal dialysis (PD) technique failure by 77% when used with an automated PD system.
Supported by the expansion and development of the healthcare infrastructure, Europe holds a significant dialysis market share. In September 2023 , Fresenius Medical Care (FME) expanded its in-house technical capabilities by opening a new head office in Huthwaite to meet the growing demand for renal therapies. Additionally, the emerging economies from the Asia Pacific region are anticipated to become the main revenue-generating areas due to the rising investment in the healthcare sector and supportive healthcare public operations.
Global Dialysis Market: Competitor Landscape
In June 2023, a United States-based manufacturer of hemodialysis products, Rockwell Medical, Inc., announced a co-promotional collaboration with B. Braun Medical for a period of 3 years. As part of the agreement, the national sales force of B. Braun will help in the promotion of hemodialysis concentrate products of Rockwell Medical in the United States region. The collaboration will ensure the supply of a wide range of high-quality hemodialysis products to the growing consumer base.
The key features of the dialysis market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Global Dialysis Market Overview
Dialysis is a procedure for people with advanced chronic kidney disease (CKD) or kidney failure. Haemodialysis and peritoneal dialysis are the two types of dialysis that can help in filtering out unwanted fluids and substances from the blood when the kidney of the patient is not working properly. Haemodialysis is the most common form of dialysis in which the blood of the patient is passed through an external dialysis machine and is usually carried out 3 days a week, with each session lasting around 4 hours.
Chronic kidney disease (CKD) results in a progressive loss of kidney function over time. It prompts the patient to undergo dialysis at an advanced stage of the disease if kidney transplantation is not a feasible option. With rise in conditions like diabetes and high blood pressure, the prevalence of CKD is on the rise, posing a greater risk for kidney failure. Approximately 37 million or 1 in 7 Americans have chronic kidney disease, prompting the need for improved and efficient dialysis products and services. Thus, the rising incidence of chronic kidney disease acts as a key driver for dialysis market growth. In addition, technological advancements and the introduction of novel products are also contributing to the increasing market demand.
Surge in Mergers and Acquisition Activities
Increased mergers and acquisitions between healthcare providers have facilitated the diversification of products and services offered in the patient dialysis market. In June 2023, Merit Medical Systems Inc., a leading manufacturer and marketer of medical devices, added USD 132.5 million worth of dialysis and related products in their existing product portfolio. With this acquisition, Merit Medical Systems aimed to expand the portfolio of its specialty dialysis devices to accommodate the rising dialysis market demand. The company purchased medical assets from two medical technology firms based in the United States, Angiodynamics Inc. and Bluegrass Vascular Technologies, for USD 100 million and USD 32.5 million, respectively. Furthermore, it is anticipated that the acquisition initiative will boost the revenue of the firm and solidify its presence in the dialysis devices market.
Increased Fundings to Boost Dialysis Market Share
Significant funding from firms, private investors, government, or non-profit organizations is bolstering the market growth of dialysis devices. In September 2023 , AWAK Technologies headquartered in Singapore, announced that it had raised over USD 20 million in Series B funding. With the help of this funding, the company will complete the ongoing human pre-pivotal clinical trial for its ultraportable peritoneal dialysis (PD) system AWAK PD. In addition, AWAK Technologies plans to develop new products promoting home dialysis and integrated digital solutions to improve the quality of life for chronic kidney disease patients.
Global Dialysis Market Segmentation
The EMR’s report titled “Dialysis Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Treatment Type
- Hemodialysis Dialysis
- Peritoneal Dialysis
- Equipment
- Consumables
- Drugs
- Services
- Other Dialysis Products
- In-center Dialysis
- Home Dialysis
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
North America has a large share of the dialysis market which can attributed to factors such as the increasing number of end stage renal disease (ESRD) patients and the rising prevalence of diabetes and hypertension. Another key factor is the rising technological advancements by the prominent healthcare companies in the region, fuelling the market size significantly. In November 2023 , Baxter International Inc., announced the launch of Sharesource, their digital health platform for home dialysis. It can reduce peritoneal dialysis (PD) technique failure by 77% when used with an automated PD system.
Supported by the expansion and development of the healthcare infrastructure, Europe holds a significant dialysis market share. In September 2023 , Fresenius Medical Care (FME) expanded its in-house technical capabilities by opening a new head office in Huthwaite to meet the growing demand for renal therapies. Additionally, the emerging economies from the Asia Pacific region are anticipated to become the main revenue-generating areas due to the rising investment in the healthcare sector and supportive healthcare public operations.
Global Dialysis Market: Competitor Landscape
In June 2023, a United States-based manufacturer of hemodialysis products, Rockwell Medical, Inc., announced a co-promotional collaboration with B. Braun Medical for a period of 3 years. As part of the agreement, the national sales force of B. Braun will help in the promotion of hemodialysis concentrate products of Rockwell Medical in the United States region. The collaboration will ensure the supply of a wide range of high-quality hemodialysis products to the growing consumer base.
The key features of the dialysis market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Nikkiso Co. Ltd
- Asahi Kasei Corporation
- Fresenius SE and Co
- Diaverum Deutschland GmbH
- B. Braun Melsungen AG
- Nipro Corporation
- Angiodynamics Inc
- Davita
- Becton, Dickinson and Company
- Baxter International Inc
- Toray Industries Inc
- Dia life
- Teleflex Incorporated
- JMS Co Ltd
- Medtronic Plc
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Dialysis Market (218-2034) Overview
- 3.1 Global Dialysis Market (2018-2034) Historical Value (2018-2024)
- 3.2 Global Dialysis Market (2018-2034) Forecast Value (2025-2034)
- 4 Global Dialysis Market (218-2034) Landscape*
- 4.1 Dialysis: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Dialysis: Product Landscape
- 4.2.1 Analysis by Treatment Type
- 4.2.2 Analysis by Product & Service
- 5 Global Dialysis Market (218-2034) Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Dialysis Market (218-2034) Segmentation
- 6.1 Global Dialysis Market (2018-2034) by Treatment Type
- 6.1.1 Market Overview
- 6.1.2 Hemodialysis Dialysis
- 6.1.3 Peritoneal Dialysis
- 6.2 Global Dialysis Market (2018-2034) by Product & Service
- 6.2.1 Market Overview
- 6.2.2 Equipment
- 6.2.3 Consumables
- 6.2.4 Drugs
- 6.2.5 Services
- 6.2.6 Other Dialysis Products
- 6.3 Global Dialysis Market (2018-2034) by End User
- 6.3.1 Market Overview
- 6.3.2 In-center Dialysis
- 6.3.3 Home Dialysis
- 6.3.4 Others
- 6.4 Global Dialysis Market (2018-2034) by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Dialysis Market (218-2034)
- 7.1 North Dialysis Market (2018-2034) by Treatment Type
- 7.1.1 Market Overview
- 7.1.2 Hemodialysis Dialysis
- 7.1.3 Peritoneal Dialysis
- 7.2 North Dialysis Market (2018-2034) by Product & Service
- 7.2.1 Market Overview
- 7.2.2 Equipment
- 7.2.3 Consumables
- 7.2.4 Drugs
- 7.2.5 Services
- 7.2.6 Other Dialysis Products
- 7.3 North Dialysis Market (2018-2034) by Country
- 7.3.1 United States of America
- 7.3.2 Canada
- 8 Europe Dialysis Market (218-2034)
- 8.1 Europe Dialysis Market (2018-2034) by Treatment Type
- 8.1.1 Market Overview
- 8.1.2 Hemodialysis Dialysis
- 8.1.3 Peritoneal Dialysis
- 8.2 Europe Dialysis Market (2018-2034) by Product & Service
- 8.2.1 Market Overview
- 8.2.2 Equipment
- 8.2.3 Consumables
- 8.2.4 Drugs
- 8.2.5 Services
- 8.2.6 Other Dialysis Products
- 8.3 Europe Dialysis Market (2018-2034) by Country
- 8.3.1 United Kingdom
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Others
- 9 Asia Pacific Dialysis Market (218-2034)
- 9.1 Asia Pacific Dialysis Market (2018-2034) by Treatment Type
- 9.1.1 Market Overview
- 9.1.2 Hemodialysis Dialysis
- 9.1.3 Peritoneal Dialysis
- 9.2 Asia Pacific Dialysis Market (2018-2034) by Product & Service
- 9.2.1 Market Overview
- 9.2.2 Equipment
- 9.2.3 Consumables
- 9.2.4 Drugs
- 9.2.5 Services
- 9.2.6 Other Dialysis Products
- 9.3 Asia Pacific Dialysis Market (2018-2034) by Country
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 Australia
- 9.3.5 ASEAN
- 9.3.6 Others
- 10 Latin America Dialysis Market (218-2034)
- 10.1 Latin Dialysis Market (2018-2034) by Treatment Type
- 10.1.1 Market Overview
- 10.1.2 Hemodialysis Dialysis
- 10.1.3 Peritoneal Dialysis
- 10.2 Latin Dialysis Market (2018-2034) by Product & Service
- 10.2.1 Market Overview
- 10.2.2 Equipment
- 10.2.3 Consumables
- 10.2.4 Drugs
- 10.2.5 Services
- 10.2.6 Other Dialysis Products
- 10.3 Latin Dialysis Market (2018-2034) by Country
- 10.3.1 Brazil
- 10.3.2 Argentina
- 10.3.3 Mexico
- 10.3.4 Others
- 11 Middle East and Africa Dialysis Market (218-2034)
- 11.1 Middle East and Africa Dialysis Market (2018-2034) by Treatment Type
- 11.1.1 Market Overview
- 11.1.2 Hemodialysis Dialysis
- 11.1.3 Peritoneal Dialysis
- 11.2 Middle East and Africa Dialysis Market (2018-2034) by Product & Service
- 11.2.1 Market Overview
- 11.2.2 Equipment
- 11.2.3 Consumables
- 11.2.4 Drugs
- 11.2.5 Services
- 11.2.6 Other Dialysis Products
- 11.3 Middle East and Africa Dialysis Market (2018-2034) by Country
- 11.3.1 Saudi Arabia
- 11.3.2 United Arab Emirates
- 11.3.3 Nigeria
- 11.3.4 South Africa
- 11.3.5 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Clinical Trials Analysis
- 15.1 Analysis by Trial Registration Year
- 15.2 Analysis by Trial Status
- 15.3 Analysis by Trial Phase
- 15.4 Analysis by Therapeutic Area
- 15.5 Analysis by Geography
- 16 Funding and Investment Analysis
- 16.1 Analysis by Funding Instances
- 16.2 Analysis by Type of Funding
- 16.3 Analysis by Funding Amount
- 16.4 Analysis by Leading Players
- 16.5 Analysis by Leading Investors
- 16.6 Analysis by Geography
- 17 Partnership and Collaborations Analysis
- 17.1 Analysis by Partnership Instances
- 17.2 Analysis by Type of Partnership
- 17.3 Analysis by Leading Players
- 17.4 Analysis by Geography
- 18 Supplier Landscape
- 18.1 NIKKISO CO. LTD
- 18.1.1 Financial Analysis
- 18.1.2 Product Portfolio
- 18.1.3 Demographic Reach and Achievements
- 18.1.4 Mergers and Acquisitions
- 18.1.5 Certifications
- 18.2 ASAHI KASEI CORPORATION
- 18.2.1 Financial Analysis
- 18.2.2 Product Portfolio
- 18.2.3 Demographic Reach and Achievements
- 18.2.4 Mergers and Acquisitions
- 18.2.5 Certifications
- 18.3 FRESENIUS SE AND CO
- 18.3.1 Financial Analysis
- 18.3.2 Product Portfolio
- 18.3.3 Demographic Reach and Achievements
- 18.3.4 Mergers and Acquisitions
- 18.3.5 Certifications
- 18.4 DIAVERUM DEUTSCHLAND GmbH
- 18.4.1 Financial Analysis
- 18.4.2 Product Portfolio
- 18.4.3 Demographic Reach and Achievements
- 18.4.4 Mergers and Acquisitions
- 18.4.5 Certifications
- 18.5 B. BRAUN MELSUNGEN AG
- 18.5.1 Financial Analysis
- 18.5.2 Product Portfolio
- 18.5.3 Demographic Reach and Achievements
- 18.5.4 Mergers and Acquisitions
- 18.5.5 Certifications
- 18.6 NIPRO CORPORATION
- 18.6.1 Financial Analysis
- 18.6.2 Product Portfolio
- 18.6.3 Demographic Reach and Achievements
- 18.6.4 Mergers and Acquisitions
- 18.6.5 Certifications
- 18.7 ANGIODYNAMICS INC
- 18.7.1 Financial Analysis
- 18.7.2 Product Portfolio
- 18.7.3 Demographic Reach and Achievements
- 18.7.4 Mergers and Acquisitions
- 18.7.5 Certifications
- 18.8 DAVITA
- 18.8.1 Financial Analysis
- 18.8.2 Product Portfolio
- 18.8.3 Demographic Reach and Achievements
- 18.8.4 Mergers and Acquisitions
- 18.8.5 Certifications
- 18.9 BECTON, DICKINSON AND COMPANY
- 18.9.1 Financial Analysis
- 18.9.2 Product Portfolio
- 18.9.3 Demographic Reach and Achievements
- 18.9.4 Mergers and Acquisitions
- 18.9.5 Certifications
- 18.10 BAXTER INTERNATIONAL INC
- 18.10.1 Financial Analysis
- 18.10.2 Product Portfolio
- 18.10.3 Demographic Reach and Achievements
- 18.10.4 Mergers and Acquisitions
- 18.10.5 Certifications
- 18.11 Toray Industries Inc
- 18.11.1 Financial Analysis
- 18.11.2 Product Portfolio
- 18.11.3 Demographic Reach and Achievements
- 18.11.4 Mergers and Acquisitions
- 18.11.5 Certifications
- 18.12 Dia life
- 18.12.1 Financial Analysis
- 18.12.2 Product Portfolio
- 18.12.3 Demographic Reach and Achievements
- 18.12.4 Mergers and Acquisitions
- 18.12.5 Certifications
- 18.13 Teleflex Incorporated
- 18.13.1 Financial Analysis
- 18.13.2 Product Portfolio
- 18.13.3 Demographic Reach and Achievements
- 18.13.4 Mergers and Acquisitions
- 18.13.5 Certifications
- 18.14 JMS Co Ltd
- 18.14.1 Financial Analysis
- 18.14.2 Product Portfolio
- 18.14.3 Demographic Reach and Achievements
- 18.14.4 Mergers and Acquisitions
- 18.14.5 Certifications
- 18.15 Medtronic Plc
- 18.15.1 Financial Analysis
- 18.15.2 Product Portfolio
- 18.15.3 Demographic Reach and Achievements
- 18.15.4 Mergers and Acquisitions
- 18.15.5 Certifications
- 19 Dialysis Market (218-2034) - Distribution Model (Additional Insight)
- 19.1 Overview
- 19.2 Potential Distributors
- 19.3 Key Parameters for Distribution Partner Assessment
- 20 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 21 Company Competitiveness Analysis (Additional Insight)
- 21.1 Very Small Companies
- 21.2 Small Companies
- 21.3 Mid-Sized Companies
- 21.4 Large Companies
- 21.5 Very Large Companies
- 22 Payment Methods (Additional Insight)
- 22.1 Government Funded
- 22.2 Private Insurance
- 22.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
